Evaluation of recurrent high-grade gliomas treated with bevacizumab: A preliminary report of 3D pseudocontinuous artery spin labeling | |
Lyu Yuelei; Liu Shuai; You Hui; Hou Bo; Wang Yu; Ma Wenbin; Feng Feng | |
2017 | |
卷号 | 46期号:2页码:565-573 |
关键词 | arterial spin labeling recurrent high-grade gliomas bevacizumab cerebral blood flow overall survival progression-free survival |
ISSN号 | 1053-1807 |
DOI | 10.1002/jmri.25558 |
URL标识 | 查看原文 |
收录类别 | SCIE ; PUBMED |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6367392 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Lyu Yuelei,Liu Shuai,You Hui,et al. Evaluation of recurrent high-grade gliomas treated with bevacizumab: A preliminary report of 3D pseudocontinuous artery spin labeling[J],2017,46(2):565-573. |
APA | Lyu Yuelei.,Liu Shuai.,You Hui.,Hou Bo.,Wang Yu.,...&Feng Feng.(2017).Evaluation of recurrent high-grade gliomas treated with bevacizumab: A preliminary report of 3D pseudocontinuous artery spin labeling.,46(2),565-573. |
MLA | Lyu Yuelei,et al."Evaluation of recurrent high-grade gliomas treated with bevacizumab: A preliminary report of 3D pseudocontinuous artery spin labeling".46.2(2017):565-573. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论